Deals activity: Europe leads in growth and value; sector rankings remain same as 2020
Deals activity by geography
Power industry deals, as captured by GlobalData’s Power Intelligence Centre, are up year-on-year (YoY) across most regions.
Europe is leading in terms of deal value, also recording the greatest increase in YoY growth in deals volume at 19.27%. Deals also slightly increased in Asia-Pacific (4.5%) and North America (8.7%).
South and Central America, ranking last in terms of deal value, has also suffered the biggest YoY decline, with deal volumes at -33.33%. The volume of deals recorded by GlobalData also decreased YoY in Middle East and Africa (-23.89%).
Deals activity by type
|Deal type||Total deal value (US$m)||Total deal count||YoY change (volume)|
A breakdown of deals by type and volume shows largely positive results; while mergers are down -76.14%, asset transactions are up 23.86%, partnerships are up 167.29%, and acquisitions have seen 42.04% growth. Financing deals have also seen positive results, with venture financing up 151.98% YoY, private equity up 156.56%, equity offerings up 27.14%, and debt offerings seeing growth of 3.8%.
Deals activity by sector
Perhaps the most notable conclusion to draw from GlobalData’s analysis of power industry deals by sector so far this year is consistency. All sectors are currently in the same relative rankings as they were at the end of 2020, with solar PV remaining in the lead with 785 deals.
Note: All numbers as of 18 June 2021. Deals captured by GlobalData cover M&As, strategic alliances, various types of financing and contract service agreements.
For more insight and data, visit GlobalData's Power Intelligence Centre.
Latest deals in brief
Ørsted acquires Brookfield Renewable Ireland for $684m
Danish wind turbine manufacturer Ørsted has acquired Brookfield Renewable’s Ireland and UK onshore wind business operator, Brookfield Renewable Ireland.
SPX to sell Transformer Solutions business to GE-Prolec
US-based infrastructure company SPX has signed an agreement to sell its Transformer Solutions business to GE-Prolec Transformers, together with its affiliates Prolec GE, for $645m.
7X Energy divests solar project to Komipo America
US-based solar energy company 7X Energy has divested a 130MWac solar project to Komipo America, a US subsidiary of Korea Midland Power.
New Energy Solar to sell renewable assets in Australia
Australian solar energy company New Energy Solar has agreed to divest two of its renewable energy assets to Banpu Energy and its affiliates for A$288m ($223m).
Taaleri SolarWind II fund acquires wind farms in Finland
The Taaleri SolarWind II fund and co-investors have acquired full ownership of two ready-to-build wind farms in Finland.
Rhizen signs oncology drug development deal with Curon
Swiss biopharma company Rhizen Pharmaceuticals has signed an exclusive licensing agreement with Curon Biopharmaceutical to develop and commercialise Tenalisib for oncology in the Greater China region. Tenalisib, a highly selective dual PI3K delta and gamma inhibitor, is currently in Phase II clinical development for haematological malignancies. The US FDA granted fast track and orphan drug designations for the drug candidate Tenalisib as a treatment for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.